| 04/02/2026 3:08 PM | Aytu BioPharma (1385818) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/17/2026 12:31 PM | Aytu BioPharma (1385818) Subject LYTTON LAURENCE W (1105806) Filed by | Form SCHEDULE 13G/A | |
| 02/13/2026 1:35 PM | AWM Investment Company, Inc. (1535264) Filed by Aytu BioPharma (1385818) Subject | Form SCHEDULE 13G/A | |
| 01/20/2026 3:05 PM | Aytu BioPharma (1385818) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 12:26 PM | Aytu BioPharma (1385818) Subject LYTTON LAURENCE W (1105806) Filed by | Form SCHEDULE 13G/A | |
| 11/12/2025 4:35 PM | Aytu BioPharma (1385818) Subject Philotimo Fund, LP (1688522) Filed by | Form SCHEDULE 13G/A | |
| 10/24/2025 3:02 PM | Aytu BioPharma (1385818) Filer | Form DEF 14A | |
| 10/24/2025 3:03 PM | Aytu BioPharma (1385818) Filer | Form DEFA14A | |
| 10/24/2025 3:04 PM | Aytu BioPharma (1385818) Filer | Form ARS | |
| 10/07/2025 3:10 PM | Aytu BioPharma (1385818) Issuer LIU VIVIAN H (1203467) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/07/2025 3:11 PM | Aytu BioPharma (1385818) Issuer Disbrow Joshua R. (1566240) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AYTU and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aytu BioPharma and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/07/2025 3:12 PM | Aytu BioPharma (1385818) Issuer Selhorn Ryan J (1670673) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/07/2025 3:15 PM | Aytu BioPharma (1385818) Issuer Disbrow Jarrett (1640724) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/07/2025 3:16 PM | Aytu BioPharma (1385818) Issuer PYSZCZYMUKA GREG (1952920) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/07/2025 3:06 PM | Aytu BioPharma (1385818) Issuer Donofrio John Jr. (1679841) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/07/2025 3:08 PM | Aytu BioPharma (1385818) Issuer DOCKERY CARL (1618149) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 3:05 PM | Aytu BioPharma (1385818) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/23/2025 3:06 PM | Aytu BioPharma (1385818) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 09/23/2025 3:08 PM | Aytu BioPharma (1385818) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 08/14/2025 1:58 PM | AWM Investment Company, Inc. (1535264) Filed by Aytu BioPharma (1385818) Subject | Form SCHEDULE 13G | |
| 06/26/2025 4:18 PM | Aytu BioPharma (1385818) Subject Philotimo Fund, LP (1688522) Filed by | Form SCHEDULE 13G/A | |
| 06/26/2025 4:31 PM | Aytu BioPharma (1385818) Subject Philotimo Fund, LP (1688522) Filed by | Form SCHEDULE 13G/A | |
| 06/26/2025 4:36 PM | Aytu BioPharma (1385818) Subject Philotimo Fund, LP (1688522) Filed by | Form SCHEDULE 13G | |
| 06/26/2025 4:01 PM | Aytu BioPharma (1385818) Subject Philotimo Fund, LP (1688522) Filed by | Form SCHEDULE 13G | |
| 06/23/2025 7:00 AM | Aytu BioPharma (1385818) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/17/2025 5:05 AM | Aytu BioPharma (1385818) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/13/2025 1:09 PM | Aytu BioPharma (1385818) Subject LYTTON LAURENCE W (1105806) Filed by | Form SCHEDULE 13G | |
| 06/10/2025 2:04 PM | Aytu BioPharma (1385818) Issuer Disbrow Joshua R. (1566240) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2025 2:06 PM | Aytu BioPharma (1385818) Issuer Disbrow Jarrett (1640724) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 5:02 AM | Aytu BioPharma (1385818) Filer | Form 424B4 | |
| 06/05/2025 11:15 PM | Aytu BioPharma (1385818) Filer | Form EFFECT | |
| 06/06/2025 5:01 AM | Aytu BioPharma (1385818) Filer | Form S-1MEF | |
| 05/21/2025 3:20 PM | Aytu BioPharma (1385818) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |